Abstract -The bovine viral diarrhea virus (BVDV) strains exist as two biotypes, cytopathic (cp) and noncytopathic (ncp), according to their effects on tissue culture cells. It has been previously reported that cell death associated to cp BVDV in vitro is mediated by apoptosis. Here, experiments were conducted to determine the involvement of the NS3 protein in the induction of apoptosis. The NS3-and NS3∆50 (deleted from the NH2-terminal 50 amino acids)-cDNA encoding sequences of BVDV NADL cp reference strain were cloned into adenoviral vectors (AdV) from which the BVDV gene of interest could be expressed from a tetracycline-responsive promoter. A549tTA cells infected in vitro with NS3 or NS3∆50-expressing AdV showed cytopathic changes characterized by cell rounding and detachment, and nucleus chromatin condensation. DNA fragmentation assays, cytochrome c release, and activation of cellular caspases performed on these infected cells clearly correlated with the observed cytopathic changes with apoptosis. The BVDV NS3∆50-induced apoptotic process was inhibited by caspase-8-and -9-specific peptide inhibitors (Z-IETD-FMK and Z-LEHD-FMK). Furthermore, apoptosis was inhibited in cells expressing the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase (HSV2-R1) or hsp70, two proteins which are known to inhibit apoptosis associated with caspase-8 activation and cytochrome c release-dependent caspase-9 activation, respectively. Given that HSV2-R1, a specific inhibitor of the caspase-8 activation pathway, efficiently suppressed apoptosis and also prevented caspase-9 activation, the overall results indicate that the BVDV NS3/NS3∆50 induces apoptosis initiated by caspase-8 activation and subsequent cytochrome c release-dependent caspase-9 activation. bovine viral diarrhea virus / NS3 protein / apoptosis / caspases
INTRODUCTION
Apoptosis is considered as the physiological form of cell death that occurs during embryonic development, tissue remodeling and tumor regression [39] . Among stimuli that have been associated with cell apoptosis are infections with mammalian DNA and RNA viruses [13] . Viruses possess various biochemical and genetic mechanisms to evade and/or induce apoptosis in infected cells through interactions at different stages of the apoptotic pathway. The fact that virusderived proteins have individually been shown to inhibit or induce apoptosis is consistent with this fact [13] .
Two major regulatory pathways of apoptosis have been identified. The extrinsic pathway is triggered by a receptor/ligand interaction mechanism which involves the recruitment of the proximal regulatory caspase-8 to the death receptor complex, resulting in cleavage of the effector caspases-3 and -7, whereas the intrinsic pathway is associated with the release of cytochrome c from mitochondria and the subsequent activation of Apaf-1, causing multimerization and autocleavage of caspase-9 and the further cleavage of the effector caspases [29, 32, 37, 41, 45] . A third pathway of apoptosis may exist, mediated by endoplasmic reticulum (ER) stress and characterized by cleavage of caspase-12 [31, 36] , further indicating the complex nature of the regulatory pathways of apoptosis.
Bovine viral diarrhea virus (BVDV) is a world-wide distributed pathogen of cattle [28, 43] . This virus, together with classical swine fever virus (CSFV) and border disease virus (BDV) in the ovine, belongs to the genus Pestivirus of the Flaviviridae family [43] . BVDV often causes subclinical infections or mild clinical signs in cattle. However, fetuses infected in the early stage of intrauterine development may become immunotolerant adults which are persistently infected with BVDV, and which will propagate the virus within the herd [28, 43] . Such animals will develop a severe fatal syndrome, termed mucosal disease (MD), characterized by profound lymphocytolysis and severe widespread ulcerations of the digestive tract [28, 43] .
The pestiviral genome is a positive, singlestranded RNA molecule of usually 12.3 kb in length that encodes one polyprotein of about 4 000 amino acids, which is co-and post-translationally processed by cell-and virus-derived proteases to give rise to the mature structural and non structural viral proteins [28] . The hallmark of BVDV strains is that they exist as two biotypes, cytopathic (cp) and noncytopathic (ncp), according to their effects on tissue culture cells [22] . NS3 is expressed only in cells infected with the cp strains [22, 27] .
Cells infected with the cp biotype of BVDV have been shown to undergo apoptosis [46] . This apoptosis process has been associated with the accumulation of large amounts of viral RNA [44] , cleavage of poly(ADP-ribose) polymerase (PARP) [14] , mitochondrial-dependent caspase-9 activation [11] , and endoplasmic reticulum (ER) stress induction that correlates with the activation of caspase-12 [18] . It is prevented by certain anti-oxidants [40] . In this report, we demonstrate that the NS3 protein of BVDV expressed from an inducible promoter in an adenovirus vector (AdV) induces programmed cell death (apoptosis) in vitro. Experiments conducted with an AdV expressing a deletion mutated form of the NS3 protein (NS3∆50) have shown that the NH2-terminal fifty amino acids of the protein are dispensable for NS3-induced apoptosis. Finally, we showed that the BVDV NS3/NS3∆50-induced apoptotic process was associated with both caspase-8 and cytochrome c release-dependent caspase-9 activation.
MATERIALS AND METHODS

Cells and viruses
The cp NADL reference strain of BVDV (ATCC # VR-534) was propagated in BVDVfree MDBK cells [4] . BMAdE1 220-8, 293A, and 293rtTA [15, 25, 26] were propagated in antibiotic-free Dulbecco minimal essential medium (DMEM) with high glucose concentration supplemented with 10% tetracycline-free fetal bovine serum (FBS) (Clontech Laboratories Inc., Palo Alto, BVDV NS3-induced apoptosis 215 USA). 293A and BMAdE1 cells were used for AdV generation and amplification [15, 26] whereas 293rtTA cells were used to assess the expression of the protein of interest and to titrate the adenovirus stocks by flow cytometry monitoring of GFP expression [26] . A549 cells (derived from human lung carcinoma tissues) genetically transformed to express the tetracycline transactivation factor (tTA) (A549tTA) [25] were used in cell apoptosis experiments conducted with the AdV. African Green Monkey kidney (Vero), canine fetal thymus (Cf2Th) and Mardin-Darby bovine kidney (MDBK) continuous cell lines were also tested to determine whether the pestiviral protein also induces apoptosis in these cells.
Viral RNA isolation and oligonucleotide primers
Viral genomic RNA was extracted using the guanidium isothiocyanate method from the supernatant of infected MDBK cells as described [1] . The oligonucleotide primers for PCR amplification of nucleic acid sequences that encode BVDV NS3 protein (nucleotides 5423 to 7471 of the viral genome; amino acids 1 to 683 of NS3) and a truncated form of NS3 (NS3∆50) (nucleotides 5573 to 7471 of the viral genome; amino acids 51 to 683 of NS3) were selected according to the BVDV NADL strain genomic sequence (Genbank Database accession number M31182), and to the predicted NH2-and COOH-termini of the protein [48] . Primers (listed in Tab. I) contained short 5' extensions in which restriction endonuclease cleavage sites, and initiation or termination codons were present for cloning/subcloning purposes. The decision to clone the sequences encoding the whole and truncated form of the NS3 protein into the eukaryotic adenovirus expression system was taken from the beginning because a negligible expression level of NS3 in bacterial cells from a prokaryotic expression construct was achieved. Deleting the NH2-terminal of NS3, which was predicted to contain several hydrophobic amino acid residues [23] , resulted in a high expression level of the protein. Thus, on the basis of these results, recombinant adenoviruses carrying the NS3 and NS3∆50-encoding sequences were constructed to maximize the likelihood of expressing the pestiviral protein in mammalian cells.
Reverse transcription-PCR
amplification, cloning, and sequencing BVDV genomic RNA was converted to complementary DNA (cDNA) by reverse transcription using random hexadeoxyribonucleotides (pd(N)6; Pharmacia Biotech Inc., Uppsala, Sweden) as previously described 
Construction of AdV
The procedures used were carried out essentially as described [15] . First, the cDNA NS3 and NS3∆50-encoding sequences were excised from plasmids pBS/Ad (NS3), and pBS/Ad (NS3∆50), respectively, with restriction enzyme PmeI, purified, and subcloned in the adenovirus transfer vector AdTR5-DC-GFPq digested with EcoRV. This transfer vector enables the gene of interest to be expressed from a tetracycline-inducible promoter in di-cistronic configuration coexpressing GFP and the BVDV protein of interest. Thereafter, 293A cells were cotransfected with FseI-restricted transfer vector, and the ClaI-restricted Ad5/∆E1∆E3 viral DNA to generate recombinant viruses by in vivo homologous recombination between overlapping sequences of linearized transfer vectors pAdTR5-DC-GFPq, and Ad5/∆E1∆E3 viral DNA [25, 26] . Adenoviral plaques were screened 10 to 15 days after cell transfection by monitoring basal GFP expression by fluorescence microscopy. AdV were then purified by three further rounds of plaque isolation on BMAdE1 cells, and expanded as described [26] . Titers of the AdV stocks were estimated by a method based on the measurement of the GFP signal by cytofluorometry [25] . AdV stocks with gene transfer unit (GTU) titers ranging from 1-3 × 10 10 per mL were obtained after 20-fold virus concentration.
Expression of BVDV NS3 and NS3∆50 in mammalian cells by Western immunoblotting
The BVDV NS3 antiserum used in this study was raised in rabbits against recombinant NS3∆50 (rNS3∆50) fusion proteins expressed in Escherichia coli [16, 20] using the pEt-21b expression vector (Novagen, Madison, USA). The cells were washed in phosphate-buffered saline (PBS) solution, pH 7.3, and lysed in standard SDS-PAGE sample buffer. Total cell extract proteins were fractionated by 15% SDS-PAGE under reducing conditions and electrotransferred onto nitrocellulose membranes. Western immunoblotting on cell extracts was performed using, as the blocking reagent solution, 5% nonfat dried milk solids and 0.05% Tween 20 in PBS [16] . The blot was incubated with rabbit preimmune serum and BVDV NS3∆50-specific antiserum for 2 h at room temperature. The membranes were then washed three times in PBS before adding a peroxidase-conjugated goat anti-rabbit immunoglobulin G (whole molecule) for 1 h at room temperature. The immunological reactivity was revealed by enhanced chemiluminescence (ECL; Perkin Elmer, Boston, USA). Thereafter, the membranes were stripped off for actin immunostaining (Chemicon, Temecula, USA).
Apoptosis analysis
AdV infection
In order to determine the apoptotic capability of BVDV NS3 or NS3∆50, one-day old (sub-confluent) A549tTA cells were infected with each of the AdV expressing the respective BVDV protein at a multiplicity of infection (MOI) value of 100-200 GTU/cell [25] . The most appropriate infective dose with no or minimal background toxic effect on the cell culture monolayer was determined for each virus stock. An AdV only expressing GFP (AdV-GFP) with the same genetic background as the AdV expressing the BVDV protein was used as a negative control, whereas cells treated with actinomycin D (50 µg/mL) were used as a positive control of apoptosis [3] . Culture medium used for mock infection served as an additional negative control. The cells were analyzed for BVDV gene expression or cell apoptosis indicators (see below) at different time periods post infection (pi).
For Vero, Cf2Th, and MDBK cell infection, the cells were first exposed to an AdV expressing the tetracycline-regulated transactivator (AdV-tTA) [25] 3 h prior to adding the AdV expressing the BVDV NS3∆50 or GFP alone. The cells were then analyzed for apoptosis by flow cytometry as described below.
Flow cytometry
Single cell suspensions (including adherent and nonadherent cells) were prepared at various time points following AdV infection by trypsinization, centrifugation and resuspending in 200 µL of a PBS solution containing 25 µg/mL propidium iodide (PI), 0.06% saponin, 2.5 U/mL RNAse A, and 20 µM EDTA for 20 min before cytometry analysis using a fluorescence-activated cell sorter (FACScan, Becton Dickinson, Mississauga, Canada). Cell debris were excluded from the analyses by the conventional scatter gating method. The cells with nuclei doublets were also excluded from the analyses using pulse processor boards. Ten thousand events per sample were analyzed using the Cell Quest software system (Becton Dickinson).
DNA fragmentation
The fragmentation of cellular DNA was analyzed by visualizing oligonucleosomalsized DNA fragments (DNA ladder formation) [3] . In situ DNA fragmentation from cells that were grown in coverslips (8-well Labtek chamber) was assessed using a colorimetric Tdt-mediated dUTP nick end labeling (TUNEL) commercial kit (In situ Cell Death Detection, POD; Roche Diagnostics, Mannheim, Germany), according to the supplier's instructions.
Detection of poly(ADP-ribose) polymerase (PARP) cleavage
Adherent cells collected at various time points following treatment (actinomycin D or cell infection with each AdV) were washed with PBS, pooled with detached cells, lysed in standard SDS-PAGE sample buffer containing 6 M urea, and sonicated for 15 s on ice. Cell proteins were fractionated by 8% SDS-PAGE and electrotransferred onto nitrocellulose membranes. Immunoblotting was performed as above by using, as the primary antibody, a PARP monoclonal antibody (C-2-10; BioVision Inc., Mountain View, USA), and, as the secondary antibody, a peroxidase-conjugated goat anti-mouse immunoglobulin G (H + L chains). The membranes were developed by ECL.
Caspase enzymatic assays, and detection of pro-caspase cleavage
Caspase-3, -8, and -9 colorimetric assays were performed according to the supplier's instructions (R & D Systems, Minneapolis, USA). Briefly, A549tTA cells infected with the relevant AdV were lysed at 40 h pi in the caspase buffer (50 mM Hepes, 150 mM NaCl, 20 mM EDTA, 1 mM DTT) for 15 min on ice. The protein concentrations were determined using a commercial kit (Bio-Rad, Mississauga, Canada). The assays were performed three times in duplicates (100 µg protein per 50 µL of cell lysis buffer) in microplates using the appropriate caspase-3 (Z-DEVDpNA), -8 (Z-IETD-pNA), and -9 (Z-LEHDpNA) colorimetric substrates. The samples were analyzed in an ELISA microplate reader (Bio-Rad) at 405 nm. An increase of the OD 405 nm of > 100%, when compared to that of the mock-infected cell control, was considered as being positive.
For detection of pro-caspase cleavage, the cells were infected with AdV-NS3 and collected as above at 24 and 48 h pi. The cells were then lysed in lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 20 mM EDTA, 0.2% TritonX-100, 50 mM DTT) supplemented with a cocktail of protease inhibitors (Roche Diagnostics). Proteins (50 µg) were fractionated by 15% SDS-PAGE and immunoblotted as above. Caspase-3 and -9 specific monoclonal antibodies were purchased from R & D Systems, and caspase-8 specific polyclonal antibodies were purchased from BD Biosciences (Mississauga, Canada).
Caspase-specific peptide inhibitors, and the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase (HSV2-R1) and hsp70 biological inhibitors
A549tTA cells were plated at a density of 2.5 × 10 4 cells per well into each well of a 24-well plate. The adhered cells (3-4 h of adsorption) were treated with caspase inhibitors (50 µM) Z-VAD-FMK (pancaspase), Z-IETD-FMK (caspase-8-specifc inhibitor), or Z-LEHD-FMK (caspase-9-specific inhibitor) (R & D Systems), and, two hours later, infected with the BVDV NS3∆50-expressing AdV. The cells were replenished with the caspase inhibitors 24 h later, and collected at 48 h after infection with AdV for cytometry analysis. For HSV2-R1 and hsp70 inhibition assays, the cells were infected with both the BVDV AdV and an AdV expressing either HSV2-R1 (AdTR5-R1; AdV-HSV2-R1) [24] or hsp70 (AdTR5-hsp70-DC-BFP; AdV-hsp70) [26] , and then tested at 48 h pi for apoptosis by cytometry analysis.
Analysis of cytochrome c translocation
For cytochrome c analysis, mock-infected and AdV-NS3∆50-infected A549tTA cells were collected at various times pi. As a control of cytochrome c release, the cells were exposed to staurosporine (100 µg/mL) [33] . Subcellular fractionation of the proteins was performed according to previously described protocols [8, 10] with slight modifications. Briefly, the cells were trypsinized, centrifuged (800 × g for 5 min), lysed in a digitonin buffer (1 mg/mL digitonin, 20 mM Hepes, pH 7.4, 250 mM sucrose) supplemented with protease inhibitors for 1 min, and microcentrifuged at 11 000 × g for 2 min. The supernatant (cytosolic fraction) was collected, whereas the cell pellet was resuspended in mitochondria buffer (0.2% TritonX-100, 150 mM NaCl, 30 mM TrisHCl pH 7.2) supplemented with protease inhibitors, and incubated for 10 min at 4 °C. The cell mixture was then microcentrifuged for 15 min at 11 000 × g, and the supernatant containing the mitochondria fraction was collected. Proteins (50 µg) were fractionated by 15% SDS-PAGE and immunoblotted as above using, as the primary antibody, an anti-human cytochrome c mouse monoclonal antibody (R & D Systems), and, as the secondary antibody, a peroxidase-conjugated goat anti-mouse immunoglobulin G (H + L chains). The membranes were developed by ECL as above. Thereafter, the membranes were stripped off for actin immunostaining.
RESULTS
Cytopathogenicity correlates with BVDV NS3 and NS3∆50 expressed from AdV
Following infection of A549tTA cells with each of the BVDV protein-expressing AdV and the control AdV-GFP, the GFP signal was generally visible under fluorescence microscopy around 6 to 8 h pi. Along with the expression of GFP, the cells infected with each AdV carrying the BVDV sequences showed the first evidence of morphological changes (cell rounding and shrinking in size and cell detachment in cell culture supernatant) from 18 to 24 h pi. Microscopic observations at 40 h pi showed that most of the shrinking cells carried the characteristic apoptosis nucleus chromatin condensation with a reduction in cell volume (Fig. 1A) . No significant CPE was observed in mock-infected cells (not shown) and in cells infected with AdV-GFP (Fig. 1A) . In contrast, CPE was readily observed in cells treated with actinomycin D, which was used as a positive control of apoptosis.
Along with the appearance of CPE, both BVDV NS3 and NS3∆50 proteins, as determined by Western immunoblotting, were expressed from cells infected with each of the AdV (Fig. 1B, lanes 4 and 5, respectively) at relatively similar levels. No immune reactivity was obtained when the cell proteins were exposed to the rabbit pre-immune serum. Expression of BVDV NS3∆50 and NS3 proteins, as determined by confocal fluorescence microscopy, was observed in cells that concomitantly expressed GFP (not shown), thereby demonstrating the effectiveness of the dicistronic adenovirus expression system used in this study. Therefore, it was concluded that expression of BVDV NS3 or NS3∆50 from each AdV correlated with CPE in infected cells. 
Expression of BVDV NS3-and NS3∆50 correlates with cell DNA fragmentation
By using flow cytometry analysis, we next determined the presence of apoptotic A549tTA cells with DNA content that would decrease after sufficient endonuclease activity. By gating the cells that were GFP positive (and that presumably were also expressing the BVDV protein of interest), and by measuring the DNA content below the diploid (Go/G1) level, we were able to detect a cell peak associated with apoptosis from cells infected with the NS3-(not shown) and NS3∆50-expressing AdV, or treated with actinomycin D (used as an apoptosis positive control) ( Fig. 2A) . In contrast, no sub G0/G1 peak was observed in cells mock-infected or infected with AdV-GFP, thereby indicating the absence of apoptosis in these cells. Similar results of BVDV NS3∆50-induced apoptosis were obtained in Vero, Cf2Th and MDBK indicator cells (not shown).
Since the oligonucleosomal DNA ladder of multiples of 180-200 base pairs in apoptotic cells is considered a hallmark of apoptosis, we carried out DNA fragmentation assays. Figure 2B shows typical DNA fragmentation in cells infected with each of the lane 7) that was used as an additional positive control of apoptosis. In contrast, no DNA fragmentation was observed in the mock-infected and AdV-GFP-infected negative control cell cultures (lanes 1 and 2, respectively). To confirm, by an independent means, the cell DNA fragmentation, a colorimetric TUNEL assay was performed to detect in situ DNA fragmentation. Labeling of cell nuclei typical of DNA fragmentation was readily detected in cells infected with AdV expressing either BVDV NS3 or NS3∆50 (Fig. 1A) . In contrast, no DNA labeling was detected in cells infected with the AdV-GFP negative control.
Cleavage of the death substrate, PARP
It is well known that chromosome DNA fragmentation requires the activation of cysteine proteases of the interleukin-1β-converting enzyme (ICE), termed the caspases, leading to the cleavage of various death substrates, including the 116 kDa PARP. The kinetics of the expression of the PARP cleavage product (85 kDa), as determined by Western immunoblotting, was then conducted from cells infected with BVDV NS3∆50-expressing AdV. As shown in Figure 2C , evidence of the PARP cleavage was observed from 24 h pi at the time when CPE was readily apparent, and continued to 60 h pi. PARP cleavage was observed in cells treated with actinomycin D (lane 3). PARP cleavage was also observed in cells infected with the BVDV NS3-expressing AdV (not shown). Altogether, the results clearly indicate that BVDV NS3 and NS3∆50-induced apoptosis is mediated through a caspase activation pathway. Finally, since the results also indicated that the first NH2-terminal fifty amino acids of NS3 are dispensable for its apoptotic capability, further experiments were conducted with the BVDV NS3∆50-expressing AdV.
Caspase activation and caspase inhibition by peptide inhibitors
In light of the results indicating a caspase activation pathway for the NS3 and NS3∆50-induced apoptosis, we examined which caspase was activated in this apoptotic process. As determined in colorimetric caspase activation assays, an activation of caspase-3 and -8 was detected increasing until it reached a maximum of > 300% (as compared with that of the mock-and AdV-GFP-infected cell negative controls) at 48 h pi with the BVDV NS3∆50-expressing AdV. Interestingly, an increase of caspase-9 activation, albeit to a lower level of Figure 3 . Detection of pro-caspase cleavage products by Western immunoblotting. A549tTA cells were mock-infected, or infected with BVDV NS3∆50-expressing AdV (AdV-NS3∆50). Lane 1, mock-infected cells after 48 h of incubation; lanes 2 and 3 refer to cells infected with AdV-NS3∆50 and collected at 24 and 48 h post-infection, respectively. As a control for protein concentration, the membranes were stripped off for actin immunostaining. The molecular weights of the expected cleavage products are indicated in the left margin.
200%, was also observed. Caspase-3 and -8 activities, but not caspase-9 activity, were measurable in cells infected with an AdV expressing FasL (AdV-FasL) that was used as a positive control of caspase-8 activation. Because caspase substrates generally lack enzymatic specificity, we wished to verify whether the selected pro-caspases -8, -9, and -3 could be subjected to enzymatic cleavage, an indication of caspase activation. As shown in Figure 3 , cleavage of all pro-caspases tested (-8, -9, and -3) was detectable by 24 h pi and readily at the experiment endpoint of 48 h pi.
To demonstrate the importance of caspase activation in apoptosis induction, experiments were conducted with caspase-specific peptide inhibitors. As shown in Table II , 72 and 51% of inhibition of apoptosis were obtained in BVDV NS3∆50-expressing AdV-infected cells treated with the pan-caspase (Z-VAD-FMK), and caspase-8-specific (Z-IETD-FMK) inhibitors, respectively. Lower but significant (p < 0.001) inhibition of 42.7% was also observed in cells treated with caspase-9-specific inhibitor (Z-LEHD-FMK). By comparison, 70, 64 and 9.7% of inhibition of apoptosis were obtained with the pan-caspase, caspase-8-specific and caspase-9-specific inhibitors, respectively, from cells infected with the AdV-FasL that were used as a control of caspase-8 activation. Thus, the results obtained here suggested that the BVDV NS3∆50 induces apoptosis that correlated with both caspase-8 and caspase-9 activation.
Apoptosis inhibition by HSV2-R1 and hsp70
To confirm by independent and more specific means the results obtained with the caspase peptide inhibitors, we determined the capability of known anti-apoptotic proteins to inhibit the NS3∆50-induced apoptotic process. Here, we selected HSV2-R1, which specifically blocks caspase-8-mediated apoptosis, and hsp70, which specifically blocks the cytochrome c release-dependent caspase-9 activation pathway. As shown in Table II , HSV2-R1, when expressed in cells infected with AdV-NS3∆50, inhibited by 81% the NS3∆50-induced apoptosis, as determined by cytometry analysis. This inhibition level was comparable to the one obtained in cells co-infected with AdV-HSV2-R1 and AdV-FasL that were used as a control for the inhibition of caspase-8 activation. On the contrary, hsp70 inhibited by 63.7% the NS3∆50-induced apoptosis. As an additional negative control, no inhibition of apoptosis was observed in cells co-infected with AdV-FasL and AdVhsp70. Thus, we concluded that caspase-8 and caspase-9 activation are with no doubt associated with BVDV NS3∆50-and presumably NS3-induced apoptosis. 
Detection of cytochrome c translocation
In light of the results obtained above, we wished to determine whether the release of cytochrome c in the cytosol, a step generally involved in caspase-9 activation, could have occurred in cells infected with AdV-NS3∆50. Time course studies showed that cytochrome c was released from the mitochondria in the cytosol by 24 h pi (as shown by the faint band) and readily at the experiment end-point of 48 h pi (Fig. 4) . As a control of the caspase-9 mitochondriadependent activation pathway, the release of cytochrome c in the cytosol was readily observed from cells treated with staurosporine from 1 h post-exposition.
DISCUSSION
Caspases, present in mammalian cells as inactive protease precursors (the so-called pro-caspases), are grouped into upstream initiator caspases (caspases-8 and -9) and in downstream effector caspases (such as caspase-3, -6, or -7). Initiator caspases-8 and -9 are first activated in response to apoptotic stimuli and are responsible for processing and activation of effector caspases which, in turn, mediate apoptosis by cleaving cellular substrates that are indispensable for cell survival [32, 41, 45] . In this study, we used an AdV-inducible expression system that allowed us to express both the NS3 and the NS3∆50 of the pestivirus BVDV. The system was also used to directly determine the involvement of these proteins in the induction of apoptosis in vitro. The results have shown that the expression of both proteins (NS3 and NS3∆50) in cells infected with the respective AdV was clearly associated with the induction of CPE, cell DNA fragmentation typical of apoptosis, cleavage of the cellular substrate PARP, and/or activation of caspases.
Infection of cells in vitro with cp BVDV (whole virus) induces apoptosis through the caspase activation pathway [14, 46] . In addition, oxydative stress [40] , intracellular viral RNA accumulation [44] , caspase-12-associated ER stress [18] , and mitochondriadependent caspase-9 activation [11] have been reported to be associated with cp BVDV-induced apoptosis. Here we show that NS3/NS3∆50 of BVDV induced apoptosis, and correlated with both caspase-8 and caspase-9 activation. Caspase-8 and -9 activation was demonstrated by the measurement of caspase enzymatic activity and pro-caspase cleavage, and the inhibition results obtained with caspase-8 (Z-IETD-FMK)-and caspase-9 (Z-LEHD-FMK)-specific peptide inhibitors, and with biological HSV2-R1, and hsp70 inhibitors. HSV2-R1 blocks the activation of caspase-8 by an unknown mechanism [24] , whereas hsp70 blocks the caspase-9-associated apoptotic process by inhibiting the release of cytochrome c from mitochondria, or by a yetto-be-characterized mechanism that occurs downstream of caspase-9 activation [12, 21, 30] . The facts that both caspase-8 and -9 were activated upon NS3∆50 expression following AdV infection, and that the BVDV NS3∆50-induced apoptosis correlated with cytochrome c release, suggest that caspase-8 likely acts indirectly at the mitochondria level, resulting in the release of cytochrome c from the mitochondria, and downstream activation of caspase-9 and effector caspases, rather than directly activating caspase-3 [38] . Although other experiments are needed to unequivocally confirm this point, this interpretation is supported by the fact that inhibition of NS3∆50-associated caspase-8 activation by HSV2-R1 resulted in inhibition of caspase-9 activation as well (as determined by the absence of the cleavage form of pro-caspase-9) (not shown). In any case, our results agreed with those reported by Grummer et al. [11] where caspase-9 activation correlated with cytochrome c translocation to the cytosol in the induction of apoptosis with cp BVDV.
The caspase-8 activation observed here in BVDV NS3-induced apoptosis was consistent with that reported by other authors [35] where the Langat virus NS3-induced apoptosis was also associated with caspase-8 activation. The Langat virus is a flavivirus that, as BVDV, belongs to the Flaviviridae family. Langat NS3-associated caspase-8 activation correlated with the binding of NS3 to caspase-8. Whether the BVDV NS3 protein indeed binds caspase-8 has yet to be determined. This is an important issue to address because the Langat virus NS3 amino acid sequence only shows 22% of identity (using the BioEdit software, 5.0.9 version, and the Blosum62 matrix) with that of the BVDV NS3. The same authors [35] also showed that the Langat virus NS3 protease domain located between amino acids 1 and 181 is involved in apoptosis. Whether the BVDV NS3 protease domain (located from amino acids 56 to 181, according to the Print Database accession number PR000729) is responsible for the apoptosis observed here has yet to be confirmed. Whatever the mechanisms would be, it is possible that the overall picture of the pestivirus NS3-induced apoptosis might be different from the Langat NS3-induced apoptosis which, as opposed with the pestivirus NS3, appeared to be independent of caspase-9 activation [35] .
In recent years, several authors have reported concomitant caspase-8 and caspase-9 activation in various apoptotic systems with or without the release of cytochrome c from mitochondria [6, 17] , further demonstrating the complex nature of the apoptotic process. Although the NS3/ NS3∆50 protein induces caspase-8-and -9-dependent apoptosis, several lines of evidence suggest that several factors (cellular and/or viral) or activation pathways of apoptosis are likely to be involved in the BVDV-associated apoptosis process. The facts that oxidative stress is observed in cells infected with cp BVDV [40] , and that caspase-12-associated ER stress, a feature that was not addressed in this study, is observed in cp BVDV-induced apoptosis are consistent with the latter statement [18] . Caspase-12, which resides within the cytoplasmic side of the ER, is believed to play a central role in the ER stress-mediated apoptosis [31] and can activate caspase-8 [7] which in turn stimulates, through Bid processing, cytochrome c release and activates caspase-9 [17] . Given its association with the membranes of ER [47] , NS3 might also trigger apoptosis through caspase-12 activation. On the contrary, monocytes/macrophages infected in vitro with cp BVDV released an interferon-like molecule and another yet to identify factor in the supernatant capable of priming uninfected macrophages for activation-induced apoptosis in response to lipopolysaccharide [2, 19, 34] . In addition, the glycoprotein E rns of the pestivirus CSFV, that is also present in BVDV, has been reported to induce apoptosis in vitro [9] . Whether the E ms of BVDV is associated with apoptosis remains to be investigated. Finally, it has been recently reported that ncp BVDV appears to inhibit apoptosis associated to cp BVDV [5] . Altogether, these reports argue for the involvement of several cellular/viral factors and/or pathways involved in the regulation of the BVDV apoptotic process at least in vitro.
The results presented here show that the BVDV NS3, and thereof BVDV NS3∆50, when expressed alone from an AdVinducible expression system, induces cell apoptosis in vitro. However, the exact role of NS3 in the cytopathogenicity of BVDV in vitro and in vivo needs further clarification, particularly since the protein, in this study, was expressed without the presence of other BVDV proteins. Nonetheless, the BVDV NS3 is the first described pestivirus nonstructural protein per se able to induce apoptosis in vitro. Our results also showed that the first NH2-terminal fifty amino acids of NS3 are dispensable for the apoptotic capability of the protein, and that the NS3/ NS3∆50-induced apoptosis correlates with both caspase-8 and caspase-9 activation. Experiments are planned to further delineate the mechanisms of BVDV NS3-induced apoptosis and to determine which domains of NS3 are involved in the induction of apoptosis.
